Vanguard discloses 5.28M-share stake in Insulet (NASDAQ: PODD)
Rhea-AI Filing Summary
Insulet Corp Schedule 13G: Vanguard Capital Management reports beneficial ownership of 5,277,842 shares of Common Stock, representing 7.49% of the class as of 03/31/2026. The filing lists 698,568 shares with sole voting power and 5,277,842 shares with sole dispositive power.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 04/30/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard holds a notable 7.49% stake in Insulet as a dispositive holder.
Vanguard Capital Management reports 5,277,842 shares beneficially owned with sole dispositive power and 698,568 shares carrying sole voting power. The filing follows Schedule 13G disclosure rules for passive or qualifying institutional investors.
Key dependencies include whether holdings are held in pooled funds or managed accounts; subsequent filings could change the stake. Timing shown: ownership as of 03/31/2026 and signature dated 04/30/2026.